Titusville, NJ, United States of America

Reshema Kemps-Polanco

This inventor holds 1 USPTO granted patent. Top assignee: Aragon Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reshema Kemps-Polanco. Retrieved from https://idiyas.com/inventor/reshema-kemps-polanco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reshema Kemps-Polanco: Innovator in Anticancer Compositions

Introduction

Reshema Kemps-Polanco is a notable inventor based in Titusville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compositions. His work focuses on innovative solutions for treating androgen receptor-related diseases, including prostate cancer.

Latest Patents

Kemps-Polanco holds 1 patent for his invention titled "Anticancer compositions." This patent concerns pharmaceutical formulations of apalutamide, which can be administered to mammals, especially humans, suffering from conditions related to androgen receptors. His research aims to provide effective treatment options for patients battling prostate cancer.

Career Highlights

Throughout his career, Reshema Kemps-Polanco has been associated with Aragon Pharmaceuticals, Inc. His role at the company has allowed him to focus on groundbreaking research and development in the pharmaceutical industry. His dedication to innovation has positioned him as a key figure in the fight against cancer.

Collaborations

Kemps-Polanco has collaborated with talented professionals in his field, including Johny Bertels and Matthieu Garin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer treatment.

Conclusion

Reshema Kemps-Polanco's contributions to anticancer research exemplify the impact of innovation in medicine. His work continues to inspire advancements in the treatment of prostate cancer and other related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…